Structure |
Chemical Name |
CAS |
MF |
|
3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzoic Acid |
358390-39-3 |
C18H20N4O4 |
|
β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8- |
932042-85-8 |
C47H53NO15 |
|
(S)-Sitagliptin Phosphate |
823817-58-9 |
C16H16F6N5O5P |
|
4-[(2,3,4-TriMethoxyphenyl)Methyl]-1-piperazinecarboxylic Acid Ethyl Ester |
53531-01-4 |
C17H26N2O5 |
|
(S)-2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione |
148857-42-5 |
C11H10ClNO3 |
|
Loratadine IMpurity C |
|
C22H23ClN2O2 |
|
Metoprolol IMpurity C |
|
C15H25NO3 |
|
Metoprolol IMpurity I |
|
C15H25NO3 |
|
Telmisartan impurity D |
|
|
|
itraconazole impurity f |
|
|
|
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- |
1255529-27-1 |
C24H30ClN7O4S |
|
1-(p-Toluenesulfonyl)hoMopiperazine, 95% |
872103-28-1 |
C12H18N2O2S |
|
1,4-ditosyl-1,4-diazepane |
5769-35-7 |
C19H24N2O4S2 |
|
Flurbiprofen Impurity |
64858-90-8 |
C17H17FO2 |
|
IMp. A (EP) as DisodiuM Salt: (4S)-2-[Carboxy[[[3-(2-chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethylthiazolidine-4-carboxylic Acid DisodiuM Salt(Penicilloic Acids of Flucloxacillin DisodiuM Salt) |
|
|
|
the Metabolite of Ivabradine |
215935-23-2 |
C26H34N2O5 |
|
Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro Dasatinib |
910297-71-1 |
C16H13Cl2N5O2S |
|
Hydroxythiovardenafil |
912576-30-8 |
C23H32N6O4S2 |
|
(((((1-(6-aMino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) isopropyl Methyl dicarbonate |
1246812-43-0 |
C17H26N5O10P |
|
9(10H)-Acridinone, 6-aMino-2-ethoxy- |
144335-20-6 |
C15H14N2O2 |
|
parecoxib impurity L |
|
|
|
Rupatadine iMpurity |
169253-15-0 |
C19H19ClN2 |
|
ceftazidiMe iMpurity C |
|
|
|
pidotiMod iMpurity E |
162148-16-5 |
C9H12N2O4S |
|
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- |
1236033-03-6 |
C18H20N6O |
|
Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]- |
145591-80-6 |
C11H11NO3 |
|
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) |
477600-76-3 |
C15H21N5O |
|
MeropeneM iMpurity |
96035-23-3 |
C15H19N3O5S |
|
Ciprofloxacin EP IMpurity B |
93107-11-0 |
C17H19N3O3 |
|
Valdecoxib IMpurity-E |
1373038-63-1 |
C16H11Cl2NO5S2 |
|
Sunitinib N-Oxide |
356068-99-0 |
C22H27FN4O3 |
|
BendaMustine IMpurity D BendaMustine N-Alkylated IMpurity |
|
|
|
Cefradine IMpurity E |
|
|
|
Cetirizine IMpurity-7 |
|
C21H25ClN2O3 |
|
Dasatinib IMpurity 6 |
|
|
|
Desacetyl CefathiaMidine |
958001-61-1 |
C17H26N4O5S2 |
|
Fluconazole IMpurity D |
|
C13H12F2N6O |
|
Lercanidipine IMpurity A |
74936-74-6 |
C19H22N2O6 |
|
Loratadine 2-Chloro IMpurity |
165739-64-0 |
C22H22Cl2N2O2 |
|
Metoprolol IMpurity F |
|
C15H25NO3 |
|
Miconazole IMpurity I |
47363-37-1 |
C18H15Cl3N2O |
|
Milrinone IMpurity 1 |
|
|
|
Nicardipine Related CoMpound 2 |
64603-72-1 |
C16H14N2O6 |
|
Saxagliptin IMpurity 1 |
1564266-73-4 |
C6H10N2O |
|
Sitagliptin DeaMino IMpurity 1 |
1253056-18-6 |
C16H12F6N4O |
|
Sitagliptin Defuoro IMpurity 5 |
486460-31-5 |
C16H16F5N5O |
|
TiMolol IMpurity E |
1026075-53-5 |
C17H26N4O6S |
|
EthanediaMide iMpurity J |
|
C2H4N2O2 |
|
4,6-dichloro-2-(propylthio)pyriMidine |
1401318-10-2 |
C7H8Cl2N2S |
|
Istradefylline impurity B |
|
|
|
Ticagrelor diastereoMer |
1459719-81-3 |
C9H9F2N |
|
Mirabegron iMpurity |
1581285-26-8 |
C16H21ClN2 |
|
Sunitinib iMpurity |
356068-98-9 |
C12H19N3O2 |
|
(-)-DihydroapovincaMinic Acid Ethyl Ester |
57327-92-1 |
C22H28N2O2 |
|
(α1S,α4S,2S,5S)-2,5-DiMethyl-3,6-dioxo-α1,α4-bis(2-phenylethyl)-1,4-piperazinediacetic Acid 1,4-Diethyl Ester |
151387-05-2 |
C30H38N2O6 |
|
[2-(4-Fluorophenyl)cyclopropyl]aMine hydrochloride |
879324-66-0 |
C9H11ClFN |
|
[4-(4-AMino-7-hydroxy-6-Methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)Methanone |
105356-90-9 |
C18H23N5O4 |
|
2-(DiethylaMino)-N-(2,5-diMethylphenyl)acetaMide Hydrochloride |
1012864-23-1 |
C14H23ClN2O |
|
2-Keto-D-gulonic Acid Methyl Ester |
67776-07-2 |
C7H12O7 |
|
9,11-Dehydro-17α-cyanoMethyl Estradiol |
86153-38-0 |
C20H23NO2 |
|
DeMethyl Irbesartan |
158778-58-6 |
C24H26N6O |
|
Epiprednisolone |
600-90-8 |
C21H28O5 |
|
δ-2-CefodiziMe (2 :1 Mixture) |
120533-30-4 |
C20H20N6O7S4 |
|
8-Chloro-1-methyl-6-phenyl-4H-Imidazo[1,5-a][1,4]benzodiazepine |
59467-86-6 |
C18H14ClN3 |
|
AMisulpride IMpurity |
84859-26-7 |
C8H17NO2 |
|
Cefoxitin iMpurity E (R-Methoxy cefoxitin) |
|
|
|
DibroMo IMpurity |
1352492-08-0 |
C15H12Br2O2 |
|
ErtapeneM IMpurity DIPP |
220031-86-7 |
C18H27N2O6PS |
|
Gefitinib IMpurity 1 |
1561173-24-7 |
C15H22ClN3O3 |
|
Pitavastatin Defuoro IMpurity CalciuM Salt |
1258947-30-6 |
C50H50CaN2O8 |
|
Solifenacin Related CoMpound 4 Succinate |
862207-71-4 |
C27H32N2O6 |
|
TenoxicaM IMpurity E (2-Methylthieno[2,3-d]isothiazol-3(2H)-one-1,1-dioxide ) |
94040-09-2 |
C6H5NO3S2 |
|
(+)-(14β)-Dihydrovinpocetine |
57517-54-1 |
C22H28N2O2 |
|
D,L-Venlafaxine-d10 Hydrochloride |
1216539-56-8 |
C17H28ClNO2 |
|
Ceritinib IMpurity |
|
|
|
Melphalan IMpurity |
|
|
|
1-[2-[(5-chloro-2,4-diMethylphenyl)thio]phenyl]- Piperazine |
1240670-87-4 |
C18H21ClN2S |
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-97-7 |
C37H42F2N8O4 |
|
4-(4-broMo-3-(hydroxyMethyl)phenoxy)benzonitrile |
906673-45-8 |
C14H10BrNO2 |
|
ACT 080803 |
1433875-21-8 |
C16H13Br2N5O2 |
|
L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 1-Methylethyl ester, (P→3'),(P'→5')-diester with (2'R)-2'-deoxy-2'-fluoro-2'-Methyluridine |
1337482-17-3 |
C34H45FN4O13P2 |
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl- |
1415560-29-0 |
C13H13Br2N3O |
|
1,1'-[1,3-Propanediylbis(oxy)]bis[2,5-dimethylbenzene] |
415724-02-6 |
C19H24O2 |
|
1-Dimethylamino-2-phenylbutan-2-yl 3,4,5-trimethoxybenzoate |
92414-09-0 |
C22H29NO5 |
|
Celecoxib 2-Methyl Analog |
170569-99-0 |
C17H14F3N3O2S |
|
EMpagliflozin iMpurity 6 |
1620758-21-5 |
C32H37ClO12 |
|
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
138168-36-2 |
C18H34N4O9 |
|
Di-Norbudesonide (Mixture of DiastereoMers) |
1040085-98-0 |
C23H30O6 |
|
Linagliptin MethyldiMer |
1418133-47-7 |
C50H56N16O4 |
|
Trelagliptin Impurity isomer |
2206135-35-3 |
C18H20FN5O2 |
|
(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
C21H25ClO6 |
|
3,6-Dichloropyrazine-2-carboxaMide |
1023813-21-9 |
C5H3Cl2N3O |
|
N-acetic acid-1-aMino-3-adaMantanol |
1032564-18-3 |
C12H19NO3 |
|
9(10H)-Acridinone, 2-ethoxy-6-nitro- |
451460-48-3 |
C15H12N2O4 |
|
Olaparib iMpurity D |
|
|
|
(5-broMo-2-chlorophenyl)(4-hydroxyphenyl)Methanone |
1360568-68-8 |
C13H8BrClO2 |
|
(2-broMo-4,5-diMethylphenyl)Methanol |
1126385-20-3 |
C9H11BrO |
|
Posaconazole iMpurity 8 |
|
|
|
Dehydro Benidipine |
118935-44-7 |
C28H29N3O6 |
|
Etoposide Impurity B |
100007-56-5 |
C29H32O13 |